The licensing agreement with CombiGene has recently been renegotiated. The revised agreement is now finalized and statements concerning CombiGene’s entitlement to withdrawal have been reformulated. Levels of remuneration to Panion in the event of a withdrawal have also been adjusted.
Read more >>